Global Presence EpigenTek has a global network of distributors in more than thirty-six countries and regions, offering a significant opportunity for international sales expansion and partnership development.

Pandemic Response With the launch of SARS-CoV-2 research assays and rapid serological tests, EpigenTek's focus on addressing current global health challenges presents a unique sales opportunity to provide essential solutions to combat COVID-19 and related diseases.

Innovative Product Portfolio EpigenTek's emphasis on speed, effectiveness, and innovation in its technologies, including new kits for DNA methylation and hydroxymethylation, offers a compelling sales proposition to researchers and pharmaceutical companies seeking cutting-edge solutions.

Partnership Collaboration The strategic partnership with EpigenCare to offer personalized skincare tests based on epigenetic markers highlights collaborative sales opportunities in the consumer market segment, presenting a pathway for diversification and revenue growth.

Market Positioning EpigenTek's specialized focus on epigenetics research positions the company as a niche leader in the biotechnology industry, presenting a competitive advantage for targeted sales and marketing efforts to a specific audience seeking advanced epigenetic solutions.